Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Ratings
4 / 5
2 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Joseph K. Belanoff, M.D.$3.6B
Market Cap • 25/07/20241998
(há 26 anos)
2004
(20 years ago)
NASDAQ
Listagem
Menlo Park
Sede • California299
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CORTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.